MaryTomaykoMDPhD

Dermatology • New Haven, CT

Assistant Professor, Dermatology, Yale University School of Medicine

Join to view full profile

Dr. Tomayko is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Tomayko's full profile

Already have an account?

Office
55 Lock Street
New Haven, CT 06520
Phone+1 203-432-0076

Fax+1 203-432-7289
Is this information wrong?

Education & Training

Yale-New Haven Medical CenterResidency, Dermatology, 2001 - 2004
University of Pennsylvania Health SystemInternship, Internal Medicine, 2000 - 2001
Perelman School of Medicine at the University of PennsylvaniaClass of 2000

Certifications & Licensure

CT State Medical License 2004 - 2024
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Publications & Presentations

PubMed

Bulk and single-nucleus RNA sequencing highlight immune pathways induced in individuals during antick bite.
Xiaotian Tang, Geoffrey E Lynn, Yingjun Cui, Jiri Cerny, Gunjan Arora, Mary M Tomayko, Joseph Craft, Erol Fikrig> ;Infection and Immunity. 2023 Nov 16
1 citations
Microfluidic Immuno-Serolomic Assay Reveals Systems Level Association with COVID-19 Pathology and Vaccine Protection.
Dongjoo Kim, Giulia Biancon, Zhiliang Bai, Jennifer VanOudenhove, Yuxin Liu, Shalin Kothari, Lohith Gowda, Jennifer M Kwan, Nicholas Carlos Buitrago-Pocasangre, Nikhil...> ;Small Methods. 2023 Oct 1
3 citations
Immune checkpoint inhibitor-induced bullous pemphigoid is characterized by interleukin (IL)-4 and IL-13 expression and responds to dupilumab treatment.
William D Shipman, Katelyn Singh, Jeffrey M Cohen, Jonathan Leventhal, William Damsky, Mary M Tomayko> ;The British Journal of Dermatology. 2023 Aug 24
30 citations
High-plex protein and whole transcriptome co-mapping at cellular resolution with spatial CITE-seq.
Yang Liu, Marcello DiStasio, Graham Su, Hiromitsu Asashima, Archibald Enninful, Xiaoyu Qin, Yanxiang Deng, Jungmin Nam, Fu Gao, Pino Bordignon, Marco Cassano, Mary Tom...> ;Nature Biotechnology. 2023 Oct 1
Polyinosinic: polycytidylic acid induced inflammation enhances while lipopolysaccharide diminishes alloimmunity to platelet transfusion in mice.
Johnson Q Tran, Marcus O Muench, Betty Gaillard, Orsolya Darst, Mary M Tomayko, Rachael P Jackman> ;Frontiers in Immunology. 2023 Jan 1
1 citations
Enhanced alloresponse to platelet transfusion due to immune dysregulation following ablative chemotherapy in mice.
Rachael P Jackman, Orsolya Darst, Betty Gaillard, Johnson Q Tran, Mary M Tomayko, Marcus O Muench> ;Frontiers in Immunology. 2023 Jan 1
1 citations
Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunity.
Dongjoo Kim, Giulia Biancon, Zhiliang Bai, Jennifer VanOudenhove, Yuxin Liu, Shalin Kothari, Lohith Gowda, Jennifer M Kwan, Nicholas Carlos Buitrago-Pocasangre, Nikhil...> ;Biorxiv. 2022 Sep 2
6 citations
A novel NFkB1 mutation linking pyoderma gangrenosum and common variable immunodeficiency.
Qisi Sun, Jeff R. Gehlhausen, Marianna Freudzon, Nour Kibbi, Allen E. Bale, Keith A. Choate, Mary M. Tomayko, Ian D. Odell, Sarika Ramachandran> ;JAAD Case Reports. 2021 Oct 29
2 citations
Targeting the FcRn: A Novel Approach to the Treatment of Pemphigus.
Caroline A. Nelson, Mary M. Tomayko> ;The Journal of Investigative Dermatology. 2021 Sep 23
53 citations
Memory B cells and plasma cells: The differentiative continuum of humoral immunity
Michael P. Cancro, Mary M. Tomayko> ;Immunological Reviews. 2021 Sep 1
2 citations
Modifying a comprehensive preclinical dermatology curriculum to better teach dermatology in skin of all colors: Response to "Improving cultural competency and practici...
Amanda G. Zhou, Janet P. Hafler, Mary M. Tomayko> ;Journal of the American Academy of Dermatology. 2021 Aug 7
59 citations
Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination.
Mary M. Tomayko, William Damsky, Ramie Fathy, Devon E. McMahon, Noel Turner, Monica N. Valentin, Tena Rallis, Ohara Aivaz, Lindy P. Fox, Esther E. Freeman> ;The Journal of Allergy and Clinical Immunology. 2021 Sep 1
3 citations
COVID-19 outcomes in patients with autoimmune blistering disease.
E Hwang, M.M. Tomayko> ;The British Journal of Dermatology. 2021 Jun 9
2 citations
Roles of Bone Morphogenetic Protein Receptor 1A in Germinal Centers and Long-Lived Humoral Immunity.
Mary M. Tomayko, Selda Karaaslan, Begoña Lainez, Laura J. Conter, Eunice Song, Srividhya Venkatesan, Yuji Mishina, Mark J. Shlomchik> ;Immunohorizons. 2021 May 11
3 citations
A Niche for Plasma Cells: The Skin.
Selda Karaaslan, Mary M. Tomayko> ;The Journal of Investigative Dermatology. 2019 Dec 1
51 citations
B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors.
William Damsky, Lucia B. Jilaveanu, Noel Turner, Curtis J. Perry, Christopher R. Zito, Mary M. Tomayko, Jonathan S. Leventhal, Kevan C. Herold, Eric Meffre, Marcus Bos...> ;Journal for Immunotherapy of Cancer. 2019 Jun 14
108 citations
Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity an...
Emily Coleman, Christine J. Ko, Feng Dai, Mary M. Tomayko, Harriet M. Kluger, Jonathan S. Leventhal> ;Journal of the American Academy of Dermatology. 2019 Apr 1
6 citations
What B cell memories are made of.
Mary M. Tomayko, David Allman> ;Current Opinion in Immunology. 2019 Mar 9
129 citations
Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impac...
Jacob D. Siegel, Mariam B. Totonchy, William Damsky, Juliana Berk-Krauss, Frank M. Castiglione, Mario Sznol, Daniel P. Petrylak, Neal A. Fischbach, Sarah B. Goldberg, ...> ;Journal of the American Academy of Dermatology. 2018 Dec 1
Image Gallery: Juvenile autoimmune pemphigus presenting with diffuse gingival hypertrophy and antibodies against desmocollin 3.
Leventhal, J. S.,Haberland, C. M.,Cowper, S. E.,Tomayko, M. M.> ;Br. J. Dermatol.. 2017 Dec 02
28 citations
Podoplanin is a negative regulator of Th17 inflammation.
Alyssa Nylander, Gerald Ponath, Pierre-Paul Axisa, Mayyan Mubarak, Mary M. Tomayko, Vijay K. Kuchroo, David Pitt, David A. Hafler> ;JCI Insight. 2017 Sep 7
5 citations
Bullous systemic lupus erythematosus in a 6-year-old boy.
Alvin W. Li, Jason G. Weed, Christopher R. Stamey, Antonio Subtil, Mary M. Tomayko, Richard J. Antaya> ;Pediatric Dermatology. 2017 Aug 29
47 citations
Development of bullous pemphigoid during nivolumab therapy
William Damsky, Lauren Kole, Mary M. Tomayko> ;JAAD Case Reports. 2016 Nov 1
295 citations
CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype
Griselda V. Zuccarino-Catania, Saheli Sadanand, Florian Weisel, Mary M. Tomayko, Hailong Meng, Steven H. Kleinstein, Kim L. Good-Jacobson, Mark J. Shlomchik> ;Nature Immunology. 2014 Jul 1
40 citations
CD73 expression is dynamically regulated in the germinal center and bone marrow plasma cells are diminished in its absence.
Laura J. Conter, Eunice Song, Mark J. Shlomchik, Mary M. Tomayko> ;Plos One. 2014 Mar 24
Join now to see all

Lectures

Controversies and Difficult Questions Concerning Biologic Therapeutics
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019